Evidence map›Paper›PMID 40739364›Full record

ArticleJournal of pharmacokinetics and pharmacodynamics2025

Pharmacometrics education for all by overcoming language barriers to enhance global collaboration.

Sonia Khier, Anna H-X P Chan Kwong, Maud Harnichard, Sihem Ait-Oudhia

Abstract read
PubMed Publisher
In one paragraph

Article in Journal of pharmacokinetics and pharmacodynamics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Sonia KhierPharmacokinetics and Pharmacometrics Department - Faculty of Pharmaceutical and Biological Sciences, Montpellier University, Montpellier, France. sonia.khier@umontpellier.fr.ORCID 0000-0001-6712-8461
Anna H-X P Chan KwongPharmetheus, Paris, France.
Maud HarnichardDepartment of Educational Development - Faculty of Pharmaceutical and Biological Sciences, Montpellier University, Montpellier, France.
Sihem Ait-OudhiaQuantitative Pharmacology and Pharmacometrics (QP2), Merck & Co, Inc, Rahway, NJ, NJ, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Proficiency in English is essential in scientific disciplines; however, it is unevenly distributed globally, creating barriers for those with limited training. Research in neuroscience supports the benefits of teaching in a student's native language. Consequently, pharmacometrics, a complex and growing field, stands to gain significantly from overcoming language barriers to better train future scientists. One effective strategy is to offer pharmacometrics education in various languages, particularly in regions with low English proficiency, such as French-speaking African countries. Recently, two French-led pharmacometrics training programs were conducted in Africa, demonstrating the positive impact of such initiatives. These programs are adaptable to other countries and languages, and ultimately, they could contribute to global health improvements by making pharmacometrics education more accessible worldwide.

Indexed as

Communication BarriersLanguageAfricaGlobal HealthHumansInternational CooperationComprehensionEducationLanguageLearningPharmacometricsTraining memory

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.